CYTOKINETICS
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.
CYTOKINETICS
Industry:
Biopharma Biotechnology Health Care
Founded:
1998-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.cytokinetics.com
Total Employee:
51+
Status:
Active
Contact:
6506243010
Total Funding:
1.14 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Rheos Medicines
A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.
Resolution Therapeutics
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Reset Therapeutics
Reset Therapeutics, a biopharmaceutical company, develops and commercializes products that modulate the circadian system of the human body.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
NexImmune
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
NRx Pharmaceuticals
NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.
Neuropore Therapies
San Diego-based Neuropore, a biopharmaceuticals firm developing treatments for Parkinson's disease.
Vir Biotechnology
Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.
Vivet Therapeutics
Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Moerae Matrix
Moerae Matrix is a biopharmaceutical company developing targeted therapeutics for fibrotic diseases.
Lumos Pharma
Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.
Artax Biopharma
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
Ambit Biosciences
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Ataxion
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.
Algorithm Sciences
Algorithm Sciences is a biopharmaceutical company that focuses on treatment for rare cardiovascular diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Apexigen
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Anavex
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
Arno Therapeutics
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Antios Therapeutics
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Akeso Biopharma
Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aileron Therapeutics
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.
AEterna Zentaris
AEterna Zentaris is a drug development company that specializes in oncology and endocrine therapy.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Evofem Biosciences
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Endonovo Therapeutics
Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products.
ESCAPE Bio
ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Bone Therapeutics
Bone Therapeutics is a biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.
TRACON Pharmaceuticals
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
Trillium Therapeutics
Trillium is a biotech company focused on developing therapy treatments for cancer.
Touchlight Genetics
Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Kiadis Pharma
Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Krystal Biotech
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Humanigen
Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Kojin Therapeutics
Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Spruce Biosciences
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Synaptogenix
Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.
Silverback Therapeutics
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a biopharmaceutical company developing drugs to treat oncology and hematology.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Synergy Pharmaceuticals
Synergy Pharmaceuticals is a biopharmaceutical company developing novel therapies for the treatment of gastrointestinal conditions.
Sitari Pharmaceuticals
Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Dynavax Technologies
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Dianthus Therapeutics
Dianthus Therapeutics is a biotech company developer of therapeutics and drugs.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Dare Bioscience
Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Histogenics
Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Horizon Therapeutics
Horizon Therapeutics is a biopharmaceutical company driven to deliver breakthrough medicines to patients.
Virios Therapeutics
Virios Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.
IFM Therapeutics
DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
Genprex
Genprex is a clinical-stage biopharmaceutical company developing revolutionary immunogene therapies for cancer.
GH Research
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
GI Dynamics
GI Dynamics is a medical device company developing therapies for the treatment of type 2 diabetes and related metabolic diseases.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Onconova Therapeutics
Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Ocera Therapeutics
Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
OncoImmune
OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.
XyloCor Therapeutics
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
Cellectis
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
Epirium Bio
Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cytocom
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Complexa
Complexa, a biopharmaceutical company, develops therapies for the treatment of inflammatory, and metabolic diseases.
Celtaxsys
Celtaxsys is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Compass Therapeutics, Inc.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Promedior
Promedior is a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases.
Peptide Logic
Peptide Logic is a biopharmaceutical company developing peptide-antibody conjugates for pain.
Paratek Pharmaceuticals
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Daniel Ramos Recruiter @ Cytokinetics
Recruiter
2016-10-01
Robert Blum President & CEO @ Cytokinetics
President & CEO
2007-01-01
Ronald Vale Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator @ Cytokinetics
Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator
Patrick Gage Chairman of the Board of Directors @ Cytokinetics
Chairman of the Board of Directors
2009-11-01
James Sabry Co-founder, Cytokinetics; Senior Vice President, Genentech Partnering @ Cytokinetics
Co-founder, Cytokinetics; Senior Vice President, Genentech Partnering
Founder
Stock Details
Investors List
Royalty Pharma
Royalty Pharma investment in Post-IPO Debt - Cytokinetics
Deerfield
Deerfield investment in Post-IPO Equity - Cytokinetics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Cytokinetics
Red Abbey Venture Partners
Red Abbey Venture Partners investment in Post-IPO Equity - Cytokinetics
Vulcan
Vulcan investment in Series E - Cytokinetics
Official Site Inspections
http://www.cytokinetics.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.53 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cytokinetics"
Company | Cytokinetics
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which …See details»
Careers - Cytokinetics
Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical …See details»
Cytokinetics - Wikipedia
Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. [2] Operations began in 1998. …See details»
Investor Overview | Cytokinetics, Inc.
Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical …See details»
Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
Jan 13, 2025 SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today provided guidance for corporate milestones expected …See details»
Cytokinetics - Crunchbase Company Profile & Funding
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential …See details»
Cytokinetics - Leadership Team - The Org
The Leadership Team at Cytokinetics plays a pivotal role in guiding the company's strategic vision and operational execution. This diverse group comprises executives from various functions, …See details»
Our Vision - Cytokinetics
Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community …See details»
Cytokinetics: Culture - LinkedIn
Cytokinetics | 31,124 followers on LinkedIn. Empowering Muscle Empowering Lives | Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing ...See details»
Cytokinetics - Annual 2025
Cytokinetics What We Do As a leader in muscle biology, Cytokinetics is developing small molecule drug candidates engineered to impact muscle function and contractility.Cytokinetics …See details»
Grants and Giving Programs | Cytokinetics
Funding from the Cytokinetics Communications Grant program supports marketing and communications programming or personnel activities, depending on each organization’s …See details»
Cytokinetics, Inc. Locations - Contract Research Map
280 East Grand Avenue South San Francisco, CA 94080 Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in …See details»
SEC Filings | Cytokinetics, Inc.
Apr 21, 2025 Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and …See details»
Cytokinetics Announces Recipients of Its Seventh Annual …
Jan 30, 2025 Total of $100,000 Awarded to Five Patient Advocacy Organizations to Support Communications and Community Outreach. SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 …See details»
Cytokinetics - Craft
Oct 29, 2024 Cytokinetics has 5 employees across 2 locations and $18.47 m in annual revenue in FY 2024. See insights on Cytokinetics including office locations, competitors, revenue, …See details»
Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
Jan 13, 2025 SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today provided guidance for corporate milestones expected …See details»
Mission - Cytokinetics
Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community …See details»
Cytokinetics Q1 2025 Earnings Preview (NASDAQ:CYTK)
6 hours ago Cytokinetics (CYTK) Q1 earnings set for May 6th. Analysts expect EPS at -$1.36 and revenue growth of 210.7% YoY.See details»
Our Story | Timeline | Cytokinetics
For 25 years, Cytokinetics has been developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle …See details»
Cytokinetics Names Robert E. Landry to Board of Directors
Feb 11, 2025 Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and …See details»